Name | enalaprilat (anhydrous) |
---|---|
Synonyms |
Vasotec IV
MFCD08060099 ENALAPRILAT HYDRATE L-Proline,1-[N-(1-carboxy-3-phenylpropyl)-L-alanyl]-,(S) S-1-[N-(1-carboxy-3-phenylpropyl)-L-alanyl]-L-proline ENALAPRILAT USP(CRM STANDARD) Enalaprilat Enalapril acid Enalaprilic Acid 1-[N-[(S)-1-Carboxy-3-phenylpropyl]-L-alanyl]-L-proline N-(1(S)-carboxy-3-phenylpropyl)-L-alanyl-L-proline enalaprilate Enalapril diacid EINECS 278-459-3 |
Description | Enalaprilat (MK-422 anhydrous), the active metabolite of the oral prodrug Enalapril, is a potent, competitive and long-acting angiotensin-converting enzyme (ACE) inhibitor, with an IC50 of 1.94 nM. Enalaprilat can be used for the research of hypertension[1][2][3]. |
---|---|
Related Catalog | |
Target |
IC50: 1.94 nM (ACE)[1] |
In Vitro | Enalaprilat (1 nM-10 μM; 24 h) attenuates the IGF-I induced neonatal rat cardiac fibroblast growth (30% reduction) in a concentration-dependent fashion, with an IC50 of 90 mM[2]. |
In Vivo | Enalaprilat (0.01%-2.9% in the eyedrop solution) shows significant intraocular pressure (IOP)-lowering effect in rabbits[3]. |
References |
Density | 1.286 g/cm3 (20ºC) |
---|---|
Boiling Point | 601ºC at 760 mmHg |
Melting Point | 148-151°C |
Molecular Formula | C18H24N2O5 |
Molecular Weight | 348.39400 |
Flash Point | 317.3ºC |
Exact Mass | 348.16900 |
PSA | 106.94000 |
LogP | 1.45490 |
Hazard Codes | Xn |
---|---|
Risk Phrases | R68:Possible risk of irreversible effects. |
Safety Phrases | S22-S36/37/39 |
RTECS | DU9085000 |
HS Code | 2933990090 |
Precursor 10 | |
---|---|
DownStream 0 |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |